Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
about
Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
description
im September 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@en
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@nl
type
label
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@en
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@nl
prefLabel
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@en
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@nl
P2093
P2860
P1476
Efficacy and Safety of the Bio ...... ed Double-blind Clinical Trial
@en
P2093
Afsaneh Vosoogh
Arman Ajami
Behnaz Afrashteh
Farzin Kahkeshan
Masumeh Norani
Mostafa Qorbani
Ozra Tabatabaei-Malazy
Ramin Heshmat
P2860
P304
P407
P577
2018-09-01T00:00:00Z